Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

US FDA approves Sanofi’s Enjaymo for cold agglutinin disease treatment

pharmaceutical-business-reviewFebruary 07, 2022

Tag: CAD , Enjaymo , C1s

PharmaSources Customer Service